- New agreement aims to translate CNIO research into new potential treatment options for cancer patients
- License agreement encompasses two series of ATR inhibitors and a screening platform
More than a dozen people sit on the four boards for components of the S&P 500, of which four are women.
Executives from 16 companies, including Boeing, Oracle and Pfizer, are weighing in to support the increasingly-contentious border adjustment tax
AstraZeneca shares, meanwhile, were less-than-moved by the news.